Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency

Clinical trial NCT03442556 · TERMINATED

Trial details

NCT number: NCT03442556
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

ATM Gene Mutation BRCA1 Gene Mutation BRCA2 Gene Mutation Castration Levels of Testosterone Castration-Resistant Prostate Carcinoma Homologous Recombination Deficiency Prostate Carcinoma Metastatic in the Bone PSA Level Greater Than or Equal to Two PSA Progression Stage IV Prostate Adenocarcinoma AJCC v7

Start date: 2018-08-24
Primary completion: 2025-06-04
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.